Biomedical Implications of Heavy Metals Induced Imbalances in Redox Systems

Abstract

Several workers have extensively worked out the metal induced toxicity and have reported the toxic and carcinogenic effects of metals in human and animals. It is well known that these metals play a crucial role in facilitating normal biological functions of cells as well. One of the major mechanisms associated with heavy metal toxicity has been attributed to generation of reactive oxygen and nitrogen species, which develops imbalance between the prooxidant elements and the antioxidants (reducing elements) in the body. In this process, a shift to the former is termed as oxidative stress. The oxidative stress mediated toxicity of heavy metals involves damage primarily to liver (hepatotoxicity), central nervous system (neurotoxicity), DNA (genotoxicity), and kidney (nephrotoxicity) in animals and humans. Heavy metals are reported to impact signaling cascade and associated factors leading to apoptosis. The present review illustrates an account of the current knowledge about the effects of heavy metals (mainly arsenic, lead, mercury, and cadmium) induced oxidative stress as well as the possible remedies of metal(s) toxicity through natural/synthetic antioxidants, which may render their effects by reducing the concentration of toxic metal(s). This paper primarily concerns the clinicopathological and biomedical implications of heavy metals induced oxidative stress and their toxicity management in mammals.

Full text

We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.

References 187

1. 1.

   This reference’s wording can’t be shown under the paper’s licence.

   Not in our library

2. 2.

   Leonard SS, Harris GK, Shi X. Metal-induced oxidative stress and signal transduction. Free Radical Biology and Medicine. 2004;37(12):1921-1942.

   Not in our library10.1016/j.freeradbiomed.2004.09.010

3. 3.

   Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Current Medicinal Chemistry. 2005;12(10):1161-1208.

   Not in our library10.2174/0929867053764635

4. 4.

   Chen F, Ding M, Castranova V, Shi X. Carcinogenic metals and NF-κB activation. Molecular and Cellular Biochemistry. 2001;222(1-2):159-171.

   Not in our library

5. 5.

   Flora SJS, Mittal M, Mehta A. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian Journal of Medical Research. 2008;128(4):501-523.

   Not in our library

6. 6.

   Porter AC, Fanger GR, Vaillancourt RR. Signal transduction pathways regulated by arsenate and arsenite. Oncogene. 1999;18(54):7794-7802.

   Not in our library10.1038/sj.onc.1203214

7. 7.

   Arsenic in Drinking Water. 1999.

   Not in our library

8. 8.

   Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environmental Health Perspectives. 1992;97:259-267.

   Not in our library10.1289/ehp.9297259

9. 9.

   Hostynek JJ, Hinz RS, Lorence CR, Price M, Guy RH. Metals and the skin. Critical Reviews in Toxicology. 1993;23(2):171-235.

   Not in our library10.3109/10408449309117116

10. 10.

    Morrow PE, Beiter H, Amato F, Gibb FR. Pulmonary retention of lead: an experimental study in man. Environmental Research. 1980;21(2):373-384.

    Not in our library10.1016/0013-9351(80)90040-7

11. 11.

    Waalkes MP, Liu J, Ward JM, Diwan BA. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology. 2004;198(1–3):31-38.

    Not in our library10.1016/j.tox.2004.01.017

12. 12.

    Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC. Induction of gene amplification by arsenic. Science. 1988;241(4861):79-81.

    Not in our library10.1126/science.3388020

13. 13.

    Pi J, Horiguchi S, Sun Y, et al. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radical Biology and Medicine. 2003;35(1):102-113.

    Not in our library10.1016/s0891-5849(03)00269-7

14. 14.

    Puccetti E, Ruthardt M. Acute promylocytic leukemia: PML/RARα and the lukemic stem cell. Lukemia. 2004;18(7):1169-1175.

    Not in our library10.1038/sj.leu.2403367

15. 15.

    Guillamet E, Creus A, Ponti J, Sabbioni E, Fortaner S, Marcos R. In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline comet assay. Mutagenesis. 2004;19(2):129-135.

    Not in our library10.1093/mutage/geh005

16. 16.

    Huang C, Li J, Ding M, et al. Arsenic-induced NFκB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells. Molecular and Cellular Biochemistry. 2001;222(1-2):29-34.

    Not in our library

17. 17.

    Bode AM, Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology/Hematology. 2002;42(1):5-24.

    Not in our library10.1016/s1040-8428(01)00215-3

18. 18.

    Huang CS, Bode AM, Chen NY, et al. Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenate. Anticancer Research. 2001;21(1):261-267.

    Not in our library

19. 19.

    Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. The EMBO Journal. 1996;15(22):6269-6279.

    Not in our library

20. 20.

    Newton AC. Protein kinase C: seeing two domains. Current Biology. 1995;5(9):973-976.

    Not in our library10.1016/s0960-9822(95)00191-6

21. 21.

    Kapahi P, Takahashi T, Natoli G, et al. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. Journal of Biological Chemistry. 2000;275(46):36062-36066.

    Not in our library10.1074/jbc.m007204200

22. 22.

    Koul HK, Pal M, Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes & Cancer. 2013;4(9-10):342-359.

    Not in our library10.1177/1947601913507951

23. 23.

    Sun J, Yu M, Lu Y, et al. Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation. Cancer Letters. 2014;346:257-263.

    Not in our library10.1016/j.canlet.2014.01.002

24. 24.

    Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcinogenesis. Molecular and Cellular Biochemistry. 2004;255(1-2):67-78.

    Not in our library10.1023/b:mcbi.0000007262.26044.e8

25. 25.

    Rin K, Kawaguchi K, Yamanaka K, Tezuka M, Oku N, Okada S. DNA-Strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicals. Biological and Pharmaceutical Bulletin. 1995;18(1):45-48.

    Not in our library10.1248/bpb.18.45

26. 26.

    Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S. Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2′-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochemical and Biophysical Research Communications. 2001;287(1):66-70.

    Not in our library10.1006/bbrc.2001.5551

27. 27.

    Kolb H, Kolb-Bachofen V. Type I insulin dependent diabetes mellitus and nitric oxide. Diabetologia. 1992;35(8):796-797.

    Not in our library10.1007/bf00429103

28. 28.

    Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405-412.

    Not in our library10.2337/diab.40.4.405

29. 29.

    Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19(3):257-267.

    Not in our library10.2337/diacare.19.3.257

30. 30.

    van Dam PS, van Asbeck BS, Erkelens DW, Marx JJM, Gispen W, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes/Metabolism Reviews. 1995;11(3):181-192.

    Not in our library10.1002/dmr.5610110303

31. 31.

    Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R. Oxidative stress and the development of diabetic complications—antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biology International. 1995;19(12):987-993.

    Not in our library10.1006/cbir.1995.1040

32. 32.

    Williamson JR, Chang K, Frangos M, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42(6):801-813.

    Not in our library10.2337/diab.42.6.801

33. 33.

    Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 1997;40(6):647-653.

    Not in our library10.1007/s001250050729

34. 34.

    Brenda MS, Peter LG, Kenneth J, Chang LW. The role of general metal specific cellular responses in protection and repair of metal induced damage: stress proteins and metallothioneins. Toxicology of Metals. 1996;(chapter10):p. 167.

    Not in our library

35. 35.

    Inada C, Yamada K, Takane N, Nonaka K. Poly(ADP-ribose) synthesis induced by nitric oxide in a mouse β-cell line. Life Sciences. 1995;56(18):1467-1474.

    Not in our library10.1016/0024-3205(95)00109-j

36. 36.

    Borcea V, Nourooz-Zadeh J, Wolff SP, et al. α-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radical Biology and Medicine. 1999;26(11-12):1495-1500.

    Not in our library10.1016/s0891-5849(99)00011-8

37. 37.

    Lyons TJ. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabetic Medicine. 1991;8(5):411-419.

    Not in our library10.1111/j.1464-5491.1991.tb01624.x

38. 38.

    Sinclair JA. Free radical mechanisms and vascular complication of diabetes mellitus. Diabetes Reviews. 1993;2:7-10.

    Not in our library

39. 39.

    Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes. 1992;41(2):67-73.

    Not in our library10.2337/diab.41.2.s67

40. 40.

    Tibbetts J. How Arsenic Acts: Evidence of Oxidative Stress. 2002.

    Not in our library

Cited by papers we hold 10

• Levels of heavy metals in soil and vegetables and associated health risks in Mojo area, Ethiopia · 2020
  No notice
• Oxidative Stress: A Key Modulator in Neurodegenerative Diseases · 2019
  No notice
• Synergistic Effects of Heavy Metals and Pesticides in Living Systems · 2017
  No notice
• Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling · 2017
  No notice
• Zinc in Infection and Inflammation · 2017
  No notice
• Protective Effect of Cleistocalyx nervosum var. paniala Fruit Extract against Oxidative Renal Damage Caused by Cadmium · 2016
  Not checked
• Simultaneous exposure to multiple heavy metals and glyphosate may contribute to Sri Lankan agricultural nephropathy · 2015
  No notice
• Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants · 2015
  No notice
• Activation of Proinflammatory Responses in Cells of the Airway Mucosa by Particulate Matter: Oxidant- and Non-Oxidant-Mediated Triggering Mechanisms · 2015
  No notice
• Antioxidants of Edible Mushrooms · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.